ONC001 is a first-in-class antibody-drug conjugate (ADC) designed to uniquely target CD64, a myeloid-restricted receptor pervasively expressed in CMML and M4/M5 acute myeloid leukemia, including ...

Delve into Vandria's technology and its Alzheimer's candidate, VNA-318, the first mitophagy-based candidate in Alzheimer's in ...

And they received FDA support for Orphan Drug Designation and Fast Track Designation and they've got the opportunity to look at the IIb turning into a registration study, and that opens up the ...

TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed AML ...

"Our significant showcase at ASH this year reflects Parexel’s specialized scientific and medical expertise in hematology and our commitment to partnering with leading biopharma sponsors to advance ...

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

While pharmaceutical companies face some of the most stringent product marketing requirements in the US, the regulatory ...

Discover why Rhythm Pharmaceuticals, Inc. earns a strong buy as IMCIVREE expands in rare obesity markets. Click for this ...

An updated Canadian guideline on HIV prevention addresses the expanding range of medications available to reduce the risk of ...

Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...

Nigeria becomes the 24th out of only 25 NRAs worldwide recognised for commitment to globally harmonised pharmaceutical standards ...

The Global Life Sciences BPO Market Size projected to grow at a CAGR of 7.50% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market ...